Dihydrocodeine Bitartrate
The bitartrate salt form of dihydrocodeine, used in oral liquid and tablet preparations for pain relief and cough suppression. As a semi-synthetic opioid, it binds to opioid receptors in the brain and spinal cord to reduce pain perception. It is subject to the same abuse potential and dependency risks as other opioid analgesics.
Peso molecular
451,5000 g/mol
TPSA
157,00 Ų
Áreas terapéuticas
Mecanismo de acción
Binds to mu (μ), kappa (κ), and/or delta (δ) opioid receptors in the central and peripheral nervous system, mimicking endogenous endorphins. Activation of these G-protein-coupled receptors inhibits pain signal transmission and modulates the emotional response to pain.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Binds to mu (μ), kappa (κ), and/or delta (δ) opioid receptors in the central and peripheral nervous system, mimicking endogenous endorphins. Activation of these G-protein-coupled receptors inhibits pain signal transmission …
Estructura 2D
Cite this structure
Embed this structure
SMILES
COc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@H]4[C@@H](C2)N(C)CC[C@@]341.O=C(O)C(O)C(O)C(=O)O
InChI
InChI=1S/C18H23NO3.C4H6O6/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19;5-1(3(7)8)2(6)4(9)10/h3,6,11-13,17,20H,4-5,7-9H2,1-2H3;1-2,5-6H,(H,7,8)(H,9,10)/t11-,12+,13-,17-,18-;/m0./s1
Molecular Formula
C22H29NO9
HBD / HBA
5 / 10
Enlaces Rotables
4
Átomos Pesados
32
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Preguntas frecuentes
The bitartrate salt form of dihydrocodeine, used in oral liquid and tablet preparations for pain relief and cough suppression. As a semi-synthetic opioid, it binds to opioid receptors in the brain and spinal cord to reduce pain perception. It is subject to the same abuse potential and dependency risks as other opioid analgesics.
Binds to mu (μ), kappa (κ), and/or delta (δ) opioid receptors in the central and peripheral nervous system, mimicking endogenous endorphins. Activation of these G-protein-coupled receptors inhibits pain signal transmission and modulates the emotional response to pain.
Yes, Dihydrocodeine Bitartrate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2062266. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 5492624. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="dihydrocodeine-bitartrate"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/dihydrocodeine-bitartrate/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/dihydrocodeine-bitartrate/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/dihydrocodeine-bitartrate/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="dihydrocodeine-bitartrate"></drugfyi-drug>